IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v27y2009i1p81-90.html
   My bibliography  Save this article

Estimating the Cost of Diabetes Mellitus-Related Events from Inpatient Admissions in Sweden Using Administrative Hospitalization Data

Author

Listed:
  • Ulf-G Gerdtham
  • Philip Clarke
  • Alison Hayes
  • Soffia Gudbjornsdottir

Abstract

Background and aims: To estimate short- and long-term costs of inpatient hospitalization in Sweden for major diabetes mellitus-related events. Materials and methods: Costs were estimated using administrative hospital data from the Swedish National Board of Health and Welfare, which is linked to the Swedish National Diabetes Register. Data were available for 179 749 patients with diabetes in Sweden from 1998 to 2003 (mean and median duration of 6 years’ follow-up). Costing of inpatient admissions was based on Nordic diagnosis-related groups (NordDRG). Multiple regression analysis (linear and generalizing estimating equation models) was used to estimate inpatient care costs controlling for age, sex and co-morbidities. The data on hospitalizations were converted to costs (€) using 2003 exchange rates. Results: The average annual costs (linear model) associated with inpatient admissions for a 60-year-old male in the year the first event first occurred were as follows: €6488 (95% CI 5034, 8354) for diabetic coma; €6850 (95% CI 6514, 7204) for heart failure; €7853 (95% CI 7559, 8144) for non-fatal stroke; €8121 (95% CI 7104, 9128) for peripheral circulatory complications; €8736 (95% CI 8474, 9001) for non-fatal myocardial infarction (MI); €10 360 (95% CI 10 085, 10 643) for ischaemic heart disease; €11 411 (95%CI 10 298, 12 654) for renal failure; and €14 949 (95% CI 13 849, 16 551) for amputation. On average, the costs were higher when co-morbidity was accounted for (e.g. MI with co-morbidity was twice as costly as MI alone). Conclusions: Average hospital inpatient costs associated with common diabetes-related events can be estimated using panel data regression methods. These could assist in modelling of long-term costs of diabetes and in evaluating the cost effectiveness of improving care. Copyright Adis Data Information BV 2009

Suggested Citation

  • Ulf-G Gerdtham & Philip Clarke & Alison Hayes & Soffia Gudbjornsdottir, 2009. "Estimating the Cost of Diabetes Mellitus-Related Events from Inpatient Admissions in Sweden Using Administrative Hospitalization Data," PharmacoEconomics, Springer, vol. 27(1), pages 81-90, January.
  • Handle: RePEc:spr:pharme:v:27:y:2009:i:1:p:81-90
    DOI: 10.2165/00019053-200927010-00008
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.2165/00019053-200927010-00008
    Download Restriction: Access to full text is restricted to subscribers.

    File URL: https://libkey.io/10.2165/00019053-200927010-00008?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Anders Anell, 2005. "Swedish healthcare under pressure," Health Economics, John Wiley & Sons, Ltd., vol. 14(S1), pages 237-254, September.
    2. Gerdtham, Ulf-G., 1993. "The impact of aging on health care expenditure in Sweden," Health Policy, Elsevier, vol. 24(1), pages 1-8, April.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Tom Lung & Philip Clarke & Alison Hayes & Richard Stevens & Andrew Farmer, 2013. "Simulating Lifetime Outcomes Associated with Complications for People with Type 1 Diabetes," PharmacoEconomics, Springer, vol. 31(6), pages 509-518, June.
    2. Haruhisa Fukuda & Shunya Ikeda & Takeru Shiroiwa & Takashi Fukuda, 2016. "The Effects of Diagnostic Definitions in Claims Data on Healthcare Cost Estimates: Evidence from a Large-Scale Panel Data Analysis of Diabetes Care in Japan," PharmacoEconomics, Springer, vol. 34(10), pages 1005-1014, October.
    3. Fridhammar, Adam & Andersson, Emelie & Steen Carlsson, Katarina, 2016. "The costs of diabetes in 2020 and 2030 − A model analysis comparing innovative glucose lowering treatments in second line following European and American guidelines compared to current standard of car," IHE Report / IHE Rapport 2016:9, IHE - The Swedish Institute for Health Economics.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Fabio Pammolli & Francesco Porcelli & Francesco Vidoli & Monica Auteri & Guido Borà, 2017. "La spesa sanitaria delle Regioni in Italia - Saniregio2017," Working Papers CERM 01-2017, Competitività, Regole, Mercati (CERM).
    2. Johannesson, Magnus & Johansson, Per-Olov, 1996. "The economics of ageing: on the attitude of Swedish people to the distribution of health care resources between the young and the old," Health Policy, Elsevier, vol. 37(3), pages 153-161, September.
    3. Wickstrom, Jannie & Serup-Hansen, Niels & Kristiansen, Ivar Sonbo, 2002. "Future health care costs--do health care costs during the last year of life matter?," Health Policy, Elsevier, vol. 62(2), pages 161-172, November.
    4. Van Tielen, Rudy & Peys, Frank & Genaert, Jean, 1998. "The demographic impact on ambulatory pharmaceutical expenditure in Belgium," Health Policy, Elsevier, vol. 45(1), pages 1-14, July.
    5. Samantha Smith, 2010. "The Irish ‘health basket’: a basket case?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(3), pages 343-350, June.
    6. U.‐G. Gerdtham & M. Löthgren & M. Tambour & C. Rehnberg, 1999. "Internal markets and health care efficiency: a multiple‐output stochastic frontier analysis," Health Economics, John Wiley & Sons, Ltd., vol. 8(2), pages 151-164, March.
    7. Cecilia Gardsten & Kerstin Blomqvist & Mikael Rask & Åse Larsson & Agneta Lindberg & Gith Olsson, 2018. "Challenges in everyday life among recently diagnosed and more experienced adults with type 2 diabetes: A multistage focus group study," Journal of Clinical Nursing, John Wiley & Sons, vol. 27(19-20), pages 3666-3678, October.
    8. Vitor Castro, 2017. "Pure, White and Deadly… Expensive: A Bitter Sweetness in Health Care Expenditure," Health Economics, John Wiley & Sons, Ltd., vol. 26(12), pages 1644-1666, December.
    9. Joan Costa-i-Font & Valentina Zigante, 2014. "The Choice Agenda' in European Health Systems: The Role of 'Middle Class Demands," LEQS – LSE 'Europe in Question' Discussion Paper Series 82, European Institute, LSE.
    10. Hjelmgren, Jonas & Anell, Anders, 2007. "Population preferences and choice of primary care models: A discrete choice experiment in Sweden," Health Policy, Elsevier, vol. 83(2-3), pages 314-322, October.
    11. Karlsson, Martin & Klohn, Florian, 2011. "Some notes on how to catch a red herring: Ageing, time-to-death & care costs for older people in Sweden," Darmstadt Discussion Papers in Economics 207, Darmstadt University of Technology, Department of Law and Economics.
    12. Stefan Meyer, 2015. "Payment schemes and cost efficiency: evidence from Swiss public hospitals," International Journal of Health Economics and Management, Springer, vol. 15(1), pages 73-97, March.
    13. Ethel Yiranbon & Zhou Lulin & Henry Asante Antwi & Emmanuel Opoku Marfo & Kwame Oduro Amoako & Daniel Kwame Offin, 2014. "Evaluating the Consequences of Ageing Population on Healthcare Cost to Ghana using Inflation-Adjusted Expenditure and Demographic Factors," International Journal of Academic Research in Accounting, Finance and Management Sciences, Human Resource Management Academic Research Society, International Journal of Academic Research in Accounting, Finance and Management Sciences, vol. 4(2), pages 282-290, April.
    14. Johansson, Lennarth, 1997. "Decentralisation from acute to home care settings in Sweden," Health Policy, Elsevier, vol. 41(Supplemen), pages 131-143, September.
    15. Joan Costa-Font & Valentina Zigante, 2016. "The choice agenda in European health systems: the role of middle-class demands," Public Money & Management, Taylor & Francis Journals, vol. 36(6), pages 409-416, September.
    16. Karlsson, Martin & Klohn, Florian, 2011. "Some notes on how to catch a red herring - Ageing, time-to-death and care costs for older people in Sweden," HERO Online Working Paper Series 2011:6, University of Oslo, Health Economics Research Programme.
    17. Kristian Bolin & Anna Lindgren & Björn Lindgren & Petter Lundborg, 2009. "Utilisation of physician services in the 50+ population: the relative importance of individual versus institutional factors in 10 European countries," International Journal of Health Economics and Management, Springer, vol. 9(1), pages 83-112, March.
    18. Henriksson, Freddie & Hjortsberg, Catharina & Rehnberg, Clas, 1999. "Pharmaceutical expenditure in Sweden," Health Policy, Elsevier, vol. 47(2), pages 125-144, May.
    19. Johannesson, Magnus & Johansson, Per-Olov, 1997. "Is the valuation of a QALY gained independent of age? Some empirical evidence," Journal of Health Economics, Elsevier, vol. 16(5), pages 589-599, October.
    20. Wettermark, Björn & Godman, Brian & Neovius, Martin & Hedberg, Niklas & Mellgren, Tor-Olov & Kahan, Thomas, 2010. "Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment," Health Policy, Elsevier, vol. 94(3), pages 221-229, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:27:y:2009:i:1:p:81-90. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.